Executive Chair & Founding CEO
Karinza Phoenix
Ms Phoenix has more than 24 years of executive and commercial experience in pharmaceutical, veterinary and capital markets sectors, inclusive of holding operational and marketing roles at Pfizer, Novartis and Zoetis. Ms Phoenix has a successful track record of product development, registration and marketing launches, incorporating successful commercialisation of numerous market leading blockbuster medicines. Ms Phoenix has served on the Myopharm Board of Directors for 4 years and has invested in almost all capital raises to date, while focussing on expanding Myopharm’s clinical and commercial initiatives.
role
Executive Chair & Founding CEO
contact info
Myopharm Ltd (Pre-IPO)
As investor interest in healthcare and biotech continues to accelerate, Myopharm is positioning itself at the intersection of scientific innovation and real‑world patient impact, making this a timely and highly relevant presentation for investors seeking exposure to meaningful growth opportunities.
Myopharm is building strong momentum across its clinical and commercial programs, with several important updates expected across its pipeline and development initiatives.
Join us at Stocks in the Vines to hear Myopharm’s latest strategic update.
